BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
116 results:

  • 1. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and non-pulmonary MALT lymphoma.
    Le Y; Zhu H; Ye C; Lin J; Wang N; Yang T
    Methods; 2024 Apr; 224():54-62. PubMed ID: 38369073
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
    Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
    Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances.
    Zhao J; Li X; Liu L; Zhu Z; He C
    Front Immunol; 2023; 14():1326667. PubMed ID: 38155975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell lung cancer.
    Andrikou K; Rossi T; Verlicchi A; Priano I; Cravero P; Burgio MA; Crinò L; Bandini S; Ulivi P; Delmonte A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003273
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy.
    Zhou X; Jia Y; Mao C; Liu S
    Cancer Lett; 2024 Jan; 580():216481. PubMed ID: 37972701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Machine learning based on SPECT/CT to differentiate bone metastasis and benign bone lesions in lung malignancy patients.
    Wang H; Chen Y; Qiu J; Xie J; Lu W; Ma J; Jia M
    Med Phys; 2024 Apr; 51(4):2578-2588. PubMed ID: 37966123
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Computed tomography imaging and clinical characteristics of pulmonary ground-glass nodules ≤2 cm with micropapillary pattern.
    Guo CR; Xu L; Li X; Fu YL; Wang H; Han R; Li GS; Feng Z; Li M; Ren WG; Peng ZM
    Thorac Cancer; 2023 Dec; 14(35):3433-3444. PubMed ID: 37876115
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K/Akt/mTOR and autophagy pathways.
    Xu H; Wang J; Al-Nusaif M; Ma H; Le W
    Cell Prolif; 2024 Mar; 57(3):e13560. PubMed ID: 37850256
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
    Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
    Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic cancer.
    Qin L; Sun K; Shi L; Xu Y; Zhang R
    Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.
    Hou L; Chen X; Qiu G; Qi X; Zou Y; He J; Bu H
    J Neurooncol; 2023 Sep; 164(2):367-376. PubMed ID: 37656377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
    Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
    J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity.
    Kuang J; Duan T; Gao C; Liu C; Chen S; Zhu LY; Min L; Lu C; Wang W; Zhu L
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(4):661-671. PubMed ID: 37154586
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
    Wu Q; Wang YB; Che XW; Wang H; Wang W
    J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transcriptional adaptor 3 influences the proliferative and invasive phenotypes of non-small cell lung cancer cells via regulating emt.
    Xu LQ; Zhang SW; Zhang R; Chen JJ; Yuan ZX; Feng J; Huang JA
    Neoplasma; 2023 Apr; 70(2):240-250. PubMed ID: 37005955
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker.
    Zhang X; Deng Q; Wan X; Zhao J; Zheng X; Wang H; Wang HQ; Yang W
    Aging (Albany NY); 2023 Mar; 15(6):2115-2135. PubMed ID: 37000142
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signaling.
    Tian J; Cheng H; Wang N; Wang C
    World J Surg Oncol; 2023 Jan; 21(1):27. PubMed ID: 36721236
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in lung Adenocarcinoma.
    Chang CY; Huang YC; Chiang HH; Wu YY; Wu KL; Chang YY; Liu LX; Tsai YM; Hsu YL
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613882
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.